CD36 and Human Fat Taste Perception

Completed

• Conditions: Obesity
• Interventions: Other: No intervention

• Registration Number: NCT02699567
• Lead Sponsor: Washington University School of Medicine

Brief Summary

The purpose of this study is to determine the effect of common human variants in in taste related genes, such as CD36 gene, a putative fat taste receptor, affect fat taste perception.

Detailed Description

At present, the general agreement is that humans perceive five taste qualities: sweet, sour, bitter, salty and umami (the savory, meaty taste of some amino acids). It is believed that these qualities evolved to help us find nutrients (e.g. sweets, umami signaled calories) and avoid potential harmful substances (e.g. bitter signalized poison). Despite the fact that some fats, which can only be obtained through the diet, are essential for life, fat is not considered a basic taste; and, the issue of how fats are precisely sensed is unresolved. However, increasing evidence suggests that, in addition to smell and texture, taste plays an important role in fat perception. Putative fat taste receptor classes have been identified in animal models. One such receptor is the glycoprotein CD36, previously documented to be involved in trafficking and storage of fat. CD36 was recently found in rodents' and humans' taste buds. In rodents, CD36 deletion blunts specifically fat recognition. Although CD36 variants are frequent in humans, its role in humans' fat taste perception and preferences remains incompletely understood and will be the focus of the current proposal. The main goal of this study is to determine the effect of a common human variant in the CD36 gene on fat taste perception by using standardized sensory evaluation techniques. In addition, we will examine whether common variants in taste related genes (other than CD36) are associated with individual differences in the perception of flavors of milkshakes prepared with different amounts of fats.

Study Timeline

• Study Start: 2011-11
• Primary Completion: 2013-04
• Study Completion: 2014-07
• Status Verified: 2016-02
• Study First Submitted: 2016-02-25
• Study First Submitted QC: 2016-02-29
• Last Update Submitted: 2016-02-29
• Study First Posted: 2016-03-04
• Last Update Posted: 2016-03-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• BMI >18-<25 kg/m2 or BMI>29.9 kg/m2.
• 21 to 50 years of age

Read More

Exclusion Criteria

• Previous malabsorptive or restrictive gastrointestinal surgery
• Smoking
• Pregnancy or breastfeeding
• Diabetes
• Taking medication that might affect taste perception

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Lean AA	No intervention	Subjects with a BMI\<=25 kg/m2 and carriers of a CD36 gene variation associated with low CD36 expression levels
Lean GG	No intervention	Subjects with a BMI\<=25 kg/m2 and carriers of a CD36 gene variation associated with high CD36 expression levels
Obese GG	No intervention	Subjects with a BMI\>29.9 kg/m2 and carriers of a CD36 gene variation associated with high CD36 expression levels
Obese AA	No intervention	Subjects with a BMI\>29.9 kg/m2 and carriers of a CD36 gene variation associated with low CD36 expression levels

Primary Outcome Measures

Name	Time	Method
Scores in the general labeled magnitude scale for fat flavor intensity	One to 12 weeks following screening
Scores in the hedonic general labeled magnitude scale for fat flavor hedonic value	One to 12 weeks following screening

Secondary Outcome Measures

Name	Time	Method
Number of participants who are PROP taster as assessed by sip and spit testing procedure of water with increasing PROP concentrations.	One to 12 weeks following screening

Trial Locations

Locations (1)

Washington University School of Medicine; 🇺🇸 Saint Louis, Missouri, United States